MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Rockwell Medical ROE Ratio 2011-2026 | RMTI
Annual ROE Ratio Rockwell Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.64 | -132.42 | -1288.92 | -90.4 | -167.96 | -117.78 | -78.76 | -37.39 | -23.14 | -31.04 | -8191.46 | 542.28 | -117.54 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 542.28 | -8191.46 | -751.86 |
Quarterly ROE Ratio Rockwell Medical
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.78 | 7.98 | -1.21 | -9.91 | -24.33 | -60.47 | -57.34 | -83.31 | -100.57 | -90.54 | 98.37 | 30.03 | -12.33 | -33.82 | -144.09 | -165.6 | -118.78 | -92.81 | -65.05 | -103.7 | -120.85 | -151.33 | -132.02 | -150.24 | -129.8 | -123.99 | -83.4 | -110.87 | -108.01 | -84.69 | -78.76 | -60.84 | -54.09 | -42.69 | -37.39 | -37.11 | -32.37 | -26.31 | -23.14 | -23.17 | -25.07 | -25.62 | -31.04 | -1420.84 | -3632.93 | -5620.33 | -8191.46 | -6655.11 | -4257.8 | -2146.28 | 542.28 | 355.96 | 148.88 | 4.5 | -117.54 | -27.63 | -24.87 | -15.96 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 542.28 | -8191.46 | -582.37 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-83.89 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 3.32 | 0.3 % | $ 86.3 M |  Canada |
 |
China Pharma Holdings
CPHI
|
-61.13 | $ 0.57 | -9.62 % | $ 9.95 M |  China |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
-4.28 | $ 2.58 | 2.38 % | $ 1.34 B | Canada |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 8.01 | -0.5 % | $ 410 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 23.2 | 2.43 % | $ 1.07 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 3.13 | 2.62 % | $ 44 M | USA |
 |
Bausch Health Companies
BHC
|
57.93 | $ 4.99 | -2.25 % | $ 1.82 B | Canada |
 |
Perrigo Company plc
PRGO
|
-48.56 | $ 9.64 | 0.73 % | $ 1.34 B | USA |
 |
Harrow Health
HROW
|
-9.8 | $ 35.2 | 3.53 % | $ 1.29 B | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
223.5 | $ 4.43 | -5.34 % | $ 286 M | USA |
 |
SCYNEXIS
SCYX
|
-17.44 | $ 0.9 | 2.8 % | $ 44.9 M | USA |
 |
Solid Biosciences
SLDB
|
-96.84 | $ 6.68 | -6.44 % | $ 585 M | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.37 | 0.74 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 2.34 | -8.24 % | $ 2.9 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Relmada Therapeutics
RLMD
|
-66.33 | $ 6.1 | 4.1 % | $ 241 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 6.66 | 3.26 % | $ 4.12 B | Canada |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.34 | -1.47 % | $ 402 M | Canada |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Veru
VERU
|
-116.97 | $ 2.29 | -0.43 % | $ 309 M | USA |
 |
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | USA |
 |
TherapeuticsMD
TXMD
|
-35.09 | $ 2.29 | -0.87 % | $ 23.9 M | USA |
 |
Viatris
VTRS
|
0.27 | $ 13.36 | 0.53 % | $ 16 B | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 0.77 | 1.06 % | $ 3.32 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 2.41 | -2.43 % | $ 317 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 0.96 | -0.87 % | $ 103 M | Canada |
 |
Assertio Holdings
ASRT
|
-32.33 | $ 16.51 | 17.93 % | $ 106 M | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |